These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33527118)

  • 1. Human Immunodeficiency Virus Guidelines: Are We There Yet?
    Jenny-Avital ER
    Clin Infect Dis; 2021 Feb; 72(3):510-512. PubMed ID: 33527118
    [No Abstract]   [Full Text] [Related]  

  • 2. Human Immunodeficiency Virus-2 (HIV-2): A Summary of the Present Standard of Care and Treatment Options for Individuals Living with HIV-2 in Western Europe.
    Berzow D; Descamps D; Obermeier M; Charpentier C; Kaiser R; Guertler L; Eberle J; Wensing A; Sierra S; Ruelle J; Gomes P; Mansinho K; Taylor N; Jensen B; Döring M; Stürmer M; Rockstroh J; Camacho R
    Clin Infect Dis; 2021 Feb; 72(3):503-509. PubMed ID: 32227124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Euroguidelines in Central and Eastern Europe (ECEE) conference and the Warsaw Declaration - a comprehensive meeting report.
    Kowalska JD; Oprea C; de Witt S; Pozniak A; Gökengin D; Youle M; Lundgren JD; Horban A;
    HIV Med; 2017 May; 18(5):370-375. PubMed ID: 27553526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic epidermal necrolysis in a patient infected with human immunodeficiency virus-2.
    Girão L; Franca I; Nunes RJ; Poiares-Baptista A; Kamal-Mansinho S
    J Eur Acad Dermatol Venereol; 2002 Jan; 16(1):91-3. PubMed ID: 11952307
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent aspects of HIV and HIV-related diseases.
    Gürtler L
    Infection; 1997; 25(2):71-3. PubMed ID: 9108178
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiretroviral therapy and drug resistance in human immunodeficiency virus type 2 infection.
    Menéndez-Arias L; Alvarez M
    Antiviral Res; 2014 Feb; 102():70-86. PubMed ID: 24345729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosa-associated lymphoid tissue lymphoma in patients with human immunodeficiency virus infection.
    Boulanger E; Meignin V; Baia M; Molinier-Frenkel V; Leroy K; Oksenhendler E; Gérard L; Copie-Bergman C
    Br J Haematol; 2008 Feb; 140(4):470-4. PubMed ID: 18217893
    [No Abstract]   [Full Text] [Related]  

  • 8. General and oral manifestations of human immunodeficiency virus infection: a general overview with guidelines for infection control in the dental practice.
    de Jesús-Campos GO; Nicholoff TJ; Valenzuela RM
    J Philipp Dent Assoc; 1992; 44(1):4-14. PubMed ID: 9485769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-2EU: supporting standardized HIV-2 drug resistance interpretation in Europe.
    Charpentier C; Camacho R; Ruelle J; Kaiser R; Eberle J; Gürtler L; Pironti A; Stürmer M; Brun-Vézinet F; Descamps D; Obermeier M
    Clin Infect Dis; 2013 Jun; 56(11):1654-8. PubMed ID: 23429380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The human immunodeficiency virus type 2].
    Bektimirov TA
    Vopr Virusol; 1990; 35(3):180-3. PubMed ID: 2219846
    [No Abstract]   [Full Text] [Related]  

  • 11. [Human immunodeficiency virus: current pregnancy aspects].
    Mandelbrot L
    Arch Pediatr; 2000 May; 7 Suppl 2():295s-298s. PubMed ID: 10904750
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful Orthotopic Heart Transplantation and Immunosuppressive Management in 2 Human Immunodeficiency Virus-Seropositive Patients.
    Conte AH; Kittleson MM; Dilibero D; Hardy WD; Kobashigawa JA; Esmailian F
    Tex Heart Inst J; 2016 Feb; 43(1):69-74. PubMed ID: 27047290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoting high standards of care for women living with HIV: position statement from the Women Against Viruses in Europe Working Group.
    Kowalska JD; Aebi-Popp K; Loutfy M; Post FA; Perez-Elias MJ; Johnson M; Mulcahy F;
    HIV Med; 2018 Feb; 19(2):167-173. PubMed ID: 29159861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Viral infections--clinical pictures and laboratory diagnosis. Part 5: Human immunodeficiency virus (HIV 1, HIV 2) to measles virus].
    Burkhardt U; Eggers HJ
    Fortschr Med; 1993 Dec; 111(35-36):559-61. PubMed ID: 8307545
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiretroviral therapy in patients with dual infection with human immunodeficiency virus types 1 and 2.
    Schutten M; van der Ende ME; Osterhaus AD
    N Engl J Med; 2000 Jun; 342(23):1758-60. PubMed ID: 10858105
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV update 2005: origins, issues, prospects, and complications.
    Armstrong W; Calabrese L; Taege AJ
    Cleve Clin J Med; 2005 Jan; 72(1):73-8. PubMed ID: 15691060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic peptide assays to detect human immunodeficiency virus types 1 and 2 in seropositive individuals.
    Smith RS; Parks E
    Arch Pathol Lab Med; 1990 Mar; 114(3):254-8. PubMed ID: 2407213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spread of human immunodeficiency virus type 2 into Europe: a geographical analysis.
    Smallman-Raynor M; Cliff A
    Int J Epidemiol; 1991 Jun; 20(2):480-9. PubMed ID: 1917253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initiating highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children in Europe and the United States: comparing clinical practice to guidelines and literature evidence.
    Verweel G; Saavedra-Lozano J; van Rossum AM; Ramilo O; de Groot R
    Pediatr Infect Dis J; 2006 Nov; 25(11):987-94. PubMed ID: 17072119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An unexpected diagnosis of human immunodeficiency virus-2 infection in an overseas visitor: a case report.
    Sohail A; Van Leer L; Holmes N
    BMC Res Notes; 2017 Mar; 10(1):116. PubMed ID: 28259182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.